Guizhou Yibai Pharmaceutical Co. Ltd.SSE: 600594

Announcement on Obtaining the Drug Registration Certificate for Azacitidine for Injection

· Issued by Guizhou Yibai Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Guizhou Yibai Pharmaceutical Co. Ltd. has announced that it has received the drug registration certificate for Azacitidine for injection from the National Medical Products Administration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining the Drug Registration Certificate for Azacitidine for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix

Earlier from Guizhou Yibai Pharmaceutical

Later from Guizhou Yibai Pharmaceutical

All Guizhou Yibai Pharmaceutical news releases